• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Dissolution technologies >In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health
【24h】

In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health

机译：In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Acetylsalicylic acid is one of the most prescribed medications in the world. It is used for prevention of acute myocardial infarction, colorectal cancer, antipyretic, and as an analgesic. This study aimed to investigate the in vitro bioequivalence of three formulations of acetylsalicylic acid, simulating physiological conditions of the dissolution medium, and analyzing its possible implication for public health. A spectrophotometric method for the quantification of acetylsalicylic acid at 265 nm was used. The dissolution test was performed using a USP apparatus 2 (paddle) with 900 mL of medium at 37 +/- 0.5 degrees C and 75 rpm. At pH 4.5 and 6.8, the three formulations did not meet the criteria of very fast or fast dissolution (85% in <= 15 or 30 min, respectively). Generic A has a similarity factor (f(2)) of 50 at pH 4.5 and 80.7 at pH 6.8; generic Cf-2 values were 31.2 at pH 4.5 and 72.4 at pH 6.8. Generic B did not meet the acceptance range of the similarity factor (50-100) at pH 4.5 and 6.8. For all products tested, the dissolution efficiency was greater than 79%, and the mean dissolution time was 5.5-15.9 min. Based on the in vitro dissolution results, Generic A is bioequivalent with the innovator, whereas generics B and C are not. However, the dissolution profiles of generics A and C are similar to the innovator at pH 6.8, which is the appropriate dissolution medium for this drug.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号